🧪
hypothesis

ER-Associated Degradation (ERAD) Cross-Activation

Hypothesis

ER-Associated Degradation (ERAD) Cross-Activation

Partial translation of intron-retained GBA transcripts produces misfolded peptide fragments that mislocalize to the ER membrane rather than entering the ER lumen, causing local ER stress.
🧬 EIF2AK3 (PERK), EIF2S1 (eIF2α); HSPA5 (BiP), XBP1🎯 Composite 55%💱 $0.61▼1.2%proposed
neurodegeneration
EvidencePending (0%)📖 0 cit🗣 1 debates 4 support 3 oppose
✓ All Quality Gates Passed
Mechanistic 0.71 (15%) Evidence 0.47 (15%) Novelty 0.00 (12%) Feasibility 0.00 (12%) Impact 0.00 (12%) Druggability 0.00 (10%) Safety 0.00 (8%) Competition 0.00 (6%) Data Avail. 0.00 (5%) Reproducible 0.00 (5%) KG Connect 0.50 (8%) 0.545 composite
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite55%

🧪 Overview

Partial translation of intron-retained GBA transcripts produces misfolded peptide fragments that mislocalize to the ER membrane rather than entering the ER lumen, causing local ER stress. PERK dimerizes and auto-phosphorylates eIF2α, globally suppressing cap-dependent translation initiation. Since GBA translation requires efficient initiation due to its complex multi-domain structure, eIF2α-mediated repression disproportionately reduces GBA protein synthesis. ISRIB provides a direct pharmacological test of this mechanism.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

flowchart TD
    A["EIF2AK3 (PERK)<br/>Kinase"]
    B["EIF2S1 (eIF2alpha)<br/>Translation Initiation"]
    C["HSPA5 (BiP)<br/> chaperone"]
    D["XBP1<br/>Unfolded Protein Response"]
    E["ERAD<br/>Cross-Activation"]
    F["Proteasomal<br/>Clearance Deficit"]
    G["Synaptic<br/>Protein Dysregulation"]
    H["Neurodegeneration<br/>Proteostasis Failure"]
    A --> B
    B --> C
    C --> D
    D --> E
    E --> F
    F --> G
    G --> H
    style A fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a
    style H fill:#b71c1c,stroke:#ef9a9a,color:#ef9a9a

⚖️ Evidence

⚖️ Evidence Matrix4 supports3 contradicts
Supports
PERK activation suppresses protein synthesis in Parkinson's disease models
PMID:34542589
Supports
ER stress reduces GCase activity in neuron models
PMID:30704899
Supports
GBA enzyme requires precise ER folding and quality control
PMID:35604718
Supports
ISRIB (eIF2B activator) in Phase I trials for cognitive disorders - safety profile partially established
PMID:05039082
Contradicts
PERK activation requires substantial ER stress threshold unlikely achieved by low-abundance intron-retained transcripts
PMID:31171707
Contradicts
If PERK is activated, eIF2α phosphorylation suppresses all cap-dependent translation, not selectively GBA
PMID:34542589
Contradicts
ER stress reducing GCase activity may reflect general folding impairment rather than specific mechanism
PMID:30704899
📖 Linked Papers

No linked papers recorded for this hypothesis yet.

🏥 Translation

🧬 3D Protein Structure — EIF2AK3

No curated PDB or AlphaFold mapping for EIF2AK3 yet. Search RCSB →

🧠 GTEx v10 Brain ExpressionJSON

Median TPM across 13 brain regions for EIF2AK3 (PERK), EIF2S1 (eIF2α); HSPA5 (BiP), XBP1 from GTEx v10.

Cerebellar Hemisphere4.1 Cerebellum4.0 Spinal cord cervical c-13.4 Frontal Cortex BA92.1 Hypothalamus2.0 Substantia nigra1.9 Cortex1.9 Nucleus accumbens basal ganglia1.6 Hippocampus1.6 Caudate basal ganglia1.5 Anterior cingulate cortex BA241.5 Amygdala1.5 Putamen basal ganglia1.5median TPM (GTEx v10)

💉 Clinical Trials

No clinical trials data linked to this hypothesis yet.

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for EIF2AK3 (PERK), EIF2S1 (eIF2α); HSPA5 (BiP), XBP1 →

No DepMap CRISPR Chronos data found for EIF2AK3 (PERK), EIF2S1 (eIF2α); HSPA5 (BiP), XBP1.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▲ 0.0%
Volatility
High
0.0721
Events (7d)
1
Price History
▼1.2%

💾 Resource Usage

No resource usage or linked notebooks recorded for this hypothesis yet.

🔮 Predictions

🔎 Predictions vs Observations2 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
IF primary fibroblasts or iPSC-derived neurons carrying pathogenic intron-retained GBA transcripts are treated with ISRIB (200 nM, 4-24 hours), THEN GBA protein levels will increase by >30% relative tGBA protein abundance measured by quantitative western blot or targeted mass spectrometry will increase >30% in ISRIB-treated cells compared to vehicle controls— no observation —pending0.45
IF HEK293T cells or patient-derived fibroblasts are transfected with PERK-targeting siRNA 48 hours prior to GBA intron-retention expression, THEN phospho-eIF2α levels will be reduced by >70% and GBA pPhospho-eIF2α (SerS51) will be reduced >70% by western blot, and newly synthesized GBA protein measured by puromycin incorporation or S35-methionine pulse chase— no observation —pending0.38
🔮 Falsifiable Predictions (2)
pendingconf 45%
IF primary fibroblasts or iPSC-derived neurons carrying pathogenic intron-retained GBA transcripts are treated with ISRIB (200 nM, 4-24 hours), THEN GBA protein levels will increase by >30% relative to vehicle-treated cells, because ISRIB bypasses eIF2α-mediated translational repression to restore c
Predicted outcome: GBA protein abundance measured by quantitative western blot or targeted mass spectrometry will increase >30% in ISRIB-treated cells compared to vehicl
Falsification: GBA protein levels in ISRIB-treated cells remain within ±10% of vehicle control levels, indicating that translational repression of GBA is not rescued by eIF2B potentiation and the hypothesis is incor
pendingconf 38%
IF HEK293T cells or patient-derived fibroblasts are transfected with PERK-targeting siRNA 48 hours prior to GBA intron-retention expression, THEN phospho-eIF2α levels will be reduced by >70% and GBA protein synthesis will be restored to levels comparable to non-stressed cells, because PERK signaling
Predicted outcome: Phospho-eIF2α (SerS51) will be reduced >70% by western blot, and newly synthesized GBA protein measured by puromycin incorporation or S35-methionine p
Falsification: Silencing PERK reduces eIF2α phosphorylation but GBA protein synthesis remains suppressed (>50% below baseline), indicating an eIF2α-independent translational block or that GBA mRNA itself is degraded
View on SciDEX ↗